Eleven biopharmaceutical companies have completed a new round of financing! (August 18)
Introduction: This week, 11 biopharmaceutical companies completed financing, covering AI pharmaceuticals, neuromodulation, in vivo CAR-T, molecular diagnostics, and other sectors. Anlan Dejian has invested nearly 100
